Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial

Eosinophilic inflammation has been implicated in the pathogenesis, severity, and treatment responsiveness of chronic rhinosinusitis with nasal polyps (CRSwNP).

Source link

Products You May Like

Articles You May Like

COVID Data Tracker Weekly Review
Preparedness Training – Linda Light, LLCLinda Light, LLC
Breast Cancer Linked to Higher Odds for Dangerous A-Fib
Microbiota-derived peptide and autoimmune heart inflammation: a tale of missing data
KFF Global COVID-19 Vaccine Coverage Tool: Current and Projected Coverage – Updated as of November 23

Leave a Reply

Your email address will not be published. Required fields are marked *